Search - tctmd.com

Displaying 1 - 20 of 95

Sort: Relevancy | Date

News Conference News ISC 2026

CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy

Todd Neale

February 06, 2026

News Conference News AHA 2025

Beta-blockers Not Helpful After MI in Patients With Preserved EF

Yael L. Maxwell

November 12, 2025

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Yael L. Maxwell

July 03, 2025

News Conference News EHRA 2025

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

Todd Neale

April 08, 2025

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

News Conference News VIVA 2024

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

L.A. McKeown

November 14, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Conference News ESC 2024

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Shelley Wood

August 31, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News AHA 2023

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

L.A. McKeown

November 11, 2023

News Conference News ESC 2023

Four Intravascular Imaging Studies Shared the ESC Spotlight, Yet Shadows Persist

Shelley Wood

August 27, 2023

News Conference News SCCT 2023

Do Guidelines Make a Difference? SCCT Session Probes Impact and Equity

Todd Neale

August 04, 2023

News Conference News ACC 2023

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Michael O'Riordan

March 09, 2023

News Conference News AHA 2022

Cangrelor After Ticagrelor Pretreatment in ACS Might Be OK: SWAP-5

Yael L. Maxwell

November 11, 2022

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

Shelley Wood

May 23, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Conference News AHA 2021

Small CRAVE Trial Reassures on Caffeine Safety in Rhythm Disorders

L.A. McKeown

November 14, 2021

News Conference News ACC 2021

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

Yael L. Maxwell

May 15, 2021

News Conference News ESC 2020

COVID-19 Blamed for Weaker Research Published by Top-Tier Journals in 2020

Michael O'Riordan

September 04, 2020

News Conference News ESC 2020

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Michael O'Riordan

September 01, 2020

Advertisement

CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy

Beta-blockers Not Helpful After MI in Patients With Preserved EF

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

Four Intravascular Imaging Studies Shared the ESC Spotlight, Yet Shadows Persist

Do Guidelines Make a Difference? SCCT Session Probes Impact and Equity

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Cangrelor After Ticagrelor Pretreatment in ACS Might Be OK: SWAP-5

Dapagliflozin Boosts Health Status Across LVEF Range

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Small CRAVE Trial Reassures on Caffeine Safety in Rhythm Disorders

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

COVID-19 Blamed for Weaker Research Published by Top-Tier Journals in 2020

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content